Study Comparing BMS-986504 with Pembrolizumab and Chemotherapy Versus Placebo in First-line Treatment for Metastatic Non-small Cell Lung Cancer with MTAP Deletion | Clinical Trial

Study Comparing BMS-986504 with Pembrolizumab and Chemotherapy Versus Placebo in First-line Treatment for Metastatic Non-small Cell Lung Cancer with MTAP Deletion | Clinical Trial | Right2Hope